We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ACE2

News List

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay americanpharmaceuticalreview
October 26, 2020
Beroni Group has announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the ...
Researchers design and test protein that may lead to COVID-19 therapeutic worldpharmanews
August 18, 2020
A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.
Trial drug can significantly block early stages of COVID-19 in engineered human tissues worldpharmanews
April 07, 2020
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Previous page 1 2 Next page